Purpose of review Recent studies in the kidney have revealed that the well characterized tumor antigen mucin 1 (MUC1/Muc1) also has numerous functions in the normal and injured kidney.
INTRODUCTION
Mucin 1, known as MUC1 in humans and Muc1 in other mammals, is a multifunctional protein expressed on the apical surface of most epithelial cells (for review, see [1] [2] [3] [4] ). The numerous biological activities attributed to MUC1/Muc1 in promoting cell growth and survival, are sometimes overshadowed by its name and classification as a tethered mucin. MUC1/Muc1 does undergo autocatalytic cleavage early in its biogenesis yielding a large mucin-like subunit (>300 kDa) composed of a variable number of tandem repeats (range ) that provides cell surface protection from bacteria, viruses, and other environmental insults [5] [6] [7] [8] 9 & ]. MUC1 glycans on this subunit also bind to galectins which are associated with cross-linking cell surface proteins and thereby preventing endocytosis [10,11 & ,12] (Fig. 1) . The smaller transmembrane subunit (25 kDa) includes the 72 residue cytoplasmic tail with sites for binding adaptors for endocytosis and recycling, phosphorylation by kinases, and docking proteins involved in either signaling or transcriptional transactivation by trafficking to the nucleus (Fig. 2) [1] [2] [3] [13] [14] [15] . The cytoplasmic MUC1 activities have been primarily characterized in tumor cells where high-expression levels in tumors correlate with a poor prognosis for the patient because of its ability to promote cell growth and survival [21,22 & ,23] . In fact, the National Cancer Institute has priority ranked MUC1 at number two on a list of cancer vaccine target antigens where major criteria were immunogenicity, oncogenicity, and therapeutic function [24] . Epithelial tumors in Muc1 global knockout mice exhibit reduced growth when compared with congenic controls consistent with a role for Muc 1 in promoting tumor growth and survival [25] .
Under normal conditions the Muc1 knockout mice have no obvious phenotype except that they are more sensitive to bacterial infections [26, 27] . For this reason, the studies of MUC1/Muc1 function in stomach and lung have focused primarily on infection of either cell lines or Muc1 knockout and congenic control mice with Helicobacter pylori and Pseudomonas aeruginosa, respectively (discussed below). The function of Muc1/MUC1 in kidney has been more difficult to address as direct infection by bacteria and virus is much less common. Although sepsis does stress the kidney primarily by indirect means, the most well characterized model of acute kidney injury is produced by clamping both the renal artery and vein, or the artery alone, to produce ischemia, and studying recovery of kidney function and morphology after return of blood flow for hours to days [ A global frame-shift mutation in MUC1 causes only kidney disease, whereas mice lacking Muc 1 are seemingly normal but more susceptible to stressors.
Mucin 1 induced during IRI of the kidney stabilizes HIF1a and b-catenin, thereby enhancing the associated protective pathways.
Transient increases in mucin 1 enhance recovery from acute kidney injury, but prolonged increases lead to CKD and fibrosis.
Mucin 1 is a cell surface barrier to bacteria and viruses but also limits inflammation by regulating the NLRP3 inflammasome and TLR signaling.
fibrosis, and progressive renal failure. Mice expressing UMOD with the corresponding human mutations also have reduced urinary UMOD but exhibit hypercalciura, renal calcium crystals, and reduced immunofluorescence staining of the renal calcium channel TRPV5, which is localized to the distal convoluted tubule (DCT) and collecting ducts [37 && ]. Studies in transiently transfected human embryonic kidney (HEK)293 cells revealed that current density of TRPV5 was enhanced by either coexpression with UMOD or by addition of exogenous UMOD, through a mechanism that reduced TRPV5 endocytosis and increased its cell surface expression.
The data are consistent with a role for UMOD after shedding from the TAL in directly stabilizing TRPV5 in the distal segments of the tubule.
As MUC1 is also expressed in the TAL and found in the urine, whereas the mutant MUC1 accumulates within cells as described for UMOD mutations, similar studies were carried out in HEK293 cells to determine if MUC1 can also enhance activity of the renal TRPV5 channel. Interestingly, urinary MUC1 was also reduced in patients with calcium nephrolithiasis, a common type of kidney stone, supporting the possibility that shed MUC1 could have a role in enhancing calcium reabsorption [37 && ]. Transient expression of MUC1 in HEK293 cells revealed a MUC1 dose-dependent increase in TRPV5 surface currents associated with reduced TRPV5 endocytosis and stabilization at the cell surface [37 && ]. Earlier studies revealed that TRPV5 surface expression is also enhanced by binding galectin-1 after Klothodependent removal of sialic acid from TRPV5, and by galectin-3 binding to the N-glycan of TRPV5 [38, 39] . These more recent studies in HEK293 cells revealed that MUC1 enhancement of TRPV5 surface expression proceeds by galectin-3-dependent crosslinking of O-glycans on MUC1 with the N-glycan on TRPV5, whereas galectin-1 had no role [37 && ]. MUC1 does have an exceptionally strong glycan-dependent apical targeting signal that can redirect a basolaterally expressed protein to the apical cell surface in polarized epithelia; and the rate of MUC1 recycling from endosome to the cell surface is quite efficient and significantly higher than its rate of endocytosis (four-fold) [13, 40] . It is therefore possible that the MUC1 mucin-like subunit directly enhances surface expression of additional channels by a similar mechanism of cross-linking and maintenance at the cell surface. For example, a large genome-wide association study focused on serum concentrations of cations revealed that the highest association with low serum magnesium levels (hypomagnesemia) was a very common genetic variant of MUC1 that adds nine amino acids to the extracellular N-terminus of the protein [MUC1 single-nucleotide polymorphism (SNP): rs4072037 with coded allele frequency of 0.46] [41] . A SNP in the magnesium transporter transient receptor potential melastatin 6 was also associated with low serum magnesium but to a lesser extent than the MUC1 variant [41] . Interestingly, the MUC1 SNP was associated with higher bone mineral density and lower fasting glucose levels which could proceed by a direct interaction of either the transmembrane MUC1 or shed MUC1 with transporters within the kidney tubule [41] .
MUC1 has been previously implicated in enhancing glucose uptake and metabolism. Transfection of pancreatic tumor cells with MUC1 enhanced uptake of [ 3 H] 2-deoxyglucose, whereas knockdown of MUC1 in liver tumor cells reduced uptake [42] . Injection of the pancreatic tumor cells into mice produced tumors with significantly higher uptake of dye-coupled 2-deoxyglucose than tumors lacking MUC1. The MUC1-expressing tumor cells had increased levels of the glucose transporter GLUT1, as well as increased levels of HIF-1a and lactate dehydrogenase A, and increased staining with Ki67 (marker of cell proliferation, product of MK167 gene), a marker of cell proliferation. Studies using the same pancreatic tumor cells in culture were the first to reveal that MUC1 (small subunit) stabilizes HIF-1a by direct binding and enhances expression of downstream targets of HIF-1 by enhancing promoter occupancy of genes that shift metabolism in response to hypoxia [42] . Clearly, MUC1 can also modulate metabolism and solute transport by transcriptional means that alter the expression of enzymes and transporters. Although Wang et al. [43] showed that intestinal uptake and absorption of cholesterol was significantly reduced in Muc1 knockout mice compared with the wildtype mice by an undefined mechanism, Nath et al. [44] showed that MUC1 upregulates multidrug resistance genes including the ABCC1 (ATP Binding Cassette Subfamily C Member) gene that encodes a cholesterol efflux pump, by direct binding to the promoter region of the ABCC1 gene in pancreatic cancer cells.
LESSONS LEARNED FROM MUCIN1 ACTIVITIES DURING ACUTE KIDNEY INJURY
The mouse model of IRI results in significant damage to primarily the proximal tubule that is normally well oxygenated by the extensive renal vasculature in the cortex. Deep sequencing of microdissected adult rat renal tubule segments revealed that MUC1 was present in collecting duct>medullary loop of Henle >TAL>DCT>proximal tubule (based on reads per kilobase per million) [45 && ]. We found the highest levels of Muc1 in the DCT, collecting ducts and TAL in the kidneys of sham treated mice using IHC, but we also found Muc1 staining at very low levels in the proximal tubule that was absent in the Muc1 knockout mouse kidney ]. The appearance of Muc1 on the apical surface of the recovering proximal tubule at 3-day recovery is even more convincing using immunofluorescence microscopy and costaining with antibodies against the organic ion transporter 1 localized on the basolateral surface (Fig. 3) . Published studies indicate that MUC 1 is expressed on the apical surface of polarized epithelial cells in the proximal tubule during development and Novel roles for mucin 1 in the kidney Al-bataineh and Hughey potentially after injury, such that our findings in this mouse model is consistent with previous reports [46, 47] . A role for Muc1 in effective recovery from ischemic injury in the proximal tubule is supported by the fact that mice do not efficiently recover kidney function when Muc1 is absent [31 && ]. When we followed sCr levels in mice for 3 days after 19 min ischemia, we found that sCr peaked after 24 h in both Muc1 knockout and congenic control mice and returned to normal in control mice, but not Muc1 knockout mice, at 3-day recovery. The appearance of regenerating flatten cells in the proximal tubule after 3 days was also absent in Muc1 knockout mice [31 && ]. As MUC1 is known to co-immunoprecipitate with the transcription factors HIF-1a and b-catenin in tumor cell lines and prevent their degradation [42, 48] , we assessed levels of these two proteins in whole kidney homogenates and discovered that Muc1 stabilizes HIF-1a and b-catenin in the injured kidney [31 . MUC1 stabilization of HIF-1a and transactivation of HIF-1 target genes was previously reported in studies of pancreatic tumor cells [42] . In line with this, we found that levels of AMP-activated protein kinase (AMPK) were higher in Muc1 knockout kidneys when compared with controls, and AMPK activation by phosphorylation (phosphor-Thr 172 AMPK-a) was prolonged, indicating metabolic stress in the absence of Muc1 [31 && ]. MUC1 is also reported to stabilize b-catenin in tumor cells by blocking its phosphorylation by glycogen synthase kinase 3b [48] . Consistent with this, we found that induction of b-catenin during IRI was blocked in Muc1 knockout mice, whereas glycogen synthase kinase 3b activity was increased [32 && ]. Targeting of b-catenin to the nucleus during IRI was also completely blocked in Muc1 knockout mice, as was induction of the b-catenin protective FIGURE 3. Mucin 1 is expressed in the proximal tubule during ischemia-reperfusion injury. Mice were subjected to 19 min ischemia and recovery for t ¼ 0 or 3 days. Kidneys were fixed in PFA, embedded in paraffin, subjected to antigen retrieval, and incubated with rabbit anti-OAT1 (organic anion transporter 1) antibodies (red) to label the basolateral surface of the PT cells, and with Armenian hamster CT-2 anti-MUC1 cytoplasmic tail antibodies (green). Nuclei were stained blue. Muc1 appears on the apical surface of flatten cells in the recovering proximal tubule at 3-day recovery (yellow arrows). Glomeruli are also indicated. CT, cytoplasmic tail; MUC, mucin; OAT, organic anion transporter; PFA, paraformaldehyde; PT, proximal tubule.
pathway including stimulation of prosurvival factors (activated Akt (protein kinase B), survivin, transcription factor T-cell factor 4 and downstream target cyclin D1), and repression of pro-apoptotic factors (p53, active Bax, and cleaved caspase 3) [32 && ]. Both HIF-1a and b-catenin are induced during ischemic injury in the kidney tubule epithelial cells and transactivate complex protective pathways [50, 51] . This was established in part by finding that kidney injury and recovery is worse in mice with tubule knockout of either HIF-1a or b-catenin [51] [52] [53] . However, prolonged induction of either HIF-1a or b-catenin in response to kidney injury can progress from apparent full recovery to chronic kidney injury with fibrosis. Although studies in mice have shown that stabilization of HIF-1a expression improves the kidney's response to ischemia, prolonged HIF-1 activation through knockout of the von Hippel-Lindau E3 ligase, promotes interstitial fibrosis [50, 54] . In turn, genetic ablation of HIF-1a blocked development of fibrosis in a unilateral ureteral obstruction model of injury [55] . Haase [56] has also identified a significant correlation of percentage of tubular cells expressing HIF-1a and the stage of kidney nephropathy in diabetic patients.
Xiao et al. [57 && ] have now established that moderate ischemia (20 min) in a mouse model of IRI causes a transient induction of b-catenin and apparent full recovery of kidney morphology and function, whereas a more severe ischemia (30 min) produced a prolonged elevation of b-catenin and progression to fibrosis after just 10 days. Using mouse models, cultured kidney cells, and human biopsy specimens, Gibier et al. [58 && ] now report that prolonged aberrant activation of Muc 1 signaling is associated with the development and progression of CKD including fibrosis. In their mouse model, sustained activation of Muc1 is associated with induction of epithelial-to-mesenchymal transition (EMT) features such as fibronectin, type I collagen, and Snail 1, which have been previously reported to cause renal fibrosis in alternative mouse models of kidney injury [59] [60] [61] . Furthermore, there was a positive correlation between MUC1 expression and expression of EMT markers in human biopsies which also exhibit more interstitial fibrosis levels [58 && ]. This correlation could be explained by the role of mucin 1 in prolonged transactivation of both the HIF-1 and b-catenin protective pathways. Altogether, the data indicate that an early and transient activation of mucin 1 signaling appears to be renoprotective by promoting repair and recovery of kidney function, whereas sustained activation of mucin 1 appears to promote renal fibrosis and accelerate acute kidney injury to CKD progression [58 && ].
The promoter of the mucin 1 gene contains HIFresponsive elements and is induced by hypoxia in a HIF1-dependent manner [62] . HIF-1 also induces b-catenin expression [63] . As mucin 1 stabilizes both HIF-1a and b-catenin [1, 48] , it is clear that mucin 1 is a key figure in the kidney's normal recovery from transient ischemia and aberrant response to chronic ischemia, progressing to EMT and fibrosis.
LESSONS LEARNED FROM MUCIN1 ACTIVITIES IN OTHER TISSUES
Mucin 1 is highly expressed on the lung and gastric mucosal surfaces, and there is considerable evidence that MUC 1 provides both a physical barrier to potential pathogens, and modulates inflammatory and immune responses to bacterial infection. For example, Muc1 binds directly to the flagella of P. aeruginosa and to adhesins on H. pylori, common pathogens in lung and stomach, respectively [8, 64] . However, mucin 1 protection of these organs is primarily through its anti-inflammatory actions. P. aeruginosa stimulates alveolar macrophages to release tumor necrosis factor (TNF)-a, and TNF-a induces MUC 1 levels in airway epithelial cells. P. aeruginosa also stimulates airway epithelial cells to secrete transforming growth factor-a that activates the epidermal growth factor (EGF) receptor, the EGF receptor phosphorylates mucin 1, and mucin 1 then associates with toll-like receptor (TLR) 5 [65 && ]. Mucin 1 expressed on macrophages also regulates the host immune system during H. pylori infection and limits gastritis by negatively regulating NLRP3 (NACHT, LRR and PYD domains-containing protein) inflammasome activity that promotes IL-1b production [66 && ]. This protective effect of mucin 1 is mediated by its interaction with TLRs, effecting NF-kB signaling and inhibition of interleukin-1 receptor-associated kinase 4 activation [66 && ]. As MUC 1 is known to limit inflammation by regulating the NLRP3 inflammasome and TLR signaling, future studies will address this role during kidney injury.
CONCLUSION
Mucin 1 is essential for both normal renal function and recovery from injury. Galectin cross-linking of mucin 1 with transporters such as TRPV5 provides a novel mechanism for regulation of ion balance. In response to ischemia, mucin 1 levels increase and stabilize both HIF-1a and b-catenin to potentiate downstream protective pathways, although prolonged increases lead to CKD with fibrosis. As mucin 1 is reported to regulate inflammation in other tissues and the immune system by suppressing the NLRP3 inflammasome and TLR signaling, these topics should be the focus of future studies of renal injury. The study was the first to show that Muc1 is protective in a mouse model of acute kidney injury. Using Muc1 knockout and control mice, the authors reported that induction of Muc1 after ischemic injury stabilizes HIF-1a, enhances the HIF-1 protective pathway and prevents metabolic stress. This was also the first report that Muc1 is induced in the proximal tubule after injury. 32. 
